A mixed methods study exploring methadone treatment disclosure and perceptions of reproductive health care among women ages 18-44 years, Los Angeles, CA

被引:10
作者
Bornstein, Marta [1 ,2 ]
Berger, Agatha [3 ,4 ]
Gipson, Jessica D. [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, 650 Charles E Young Dr, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Calif Ctr Populat Res, 4284 Publ Affairs Bldg, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA
[4] Christiana Care Hlth Syst, Dept Obstet & Gynecol, 4755 Ogletown Stanton Rd, Newark, DE 19718 USA
关键词
Methadone; Opioid use disorder; Pregnancy; Reproductive health; Mixed methods; PRESCRIPTION OPIOID USE; USE DISORDERS; HEROIN USE; STIGMA; AMBIVALENCE;
D O I
10.1016/j.jsat.2020.108119
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: Opioid use disorder (OUD) and methadone treatment are increasing among women ages 18-44 years old, a population with unique healthcare needs. Despite this increase, there is little research on the healthcare experiences of women with OUD, particularly experiences with reproductive healthcare. Methods: We designed a sequential, mixed-methods study in three Los Angeles methadone clinics. In the first phase, we conducted in-depth interviews with women in methadone treatment (n = 22) (September-December 2016). After thematic coding and analysis, we designed and administered a survey to understand patterns in women's experiences and reproductive health knowledge, attitudes, and behavior (n = 50) (January-April 2018). We conducted descriptive statistics, then integrated the quantitative and qualitative findings to contextualize and understand perceptions and experiences with healthcare providers among women in methadone treatment. Results: We found that women experienced and anticipated that providers would treat them poorly when they disclosed that they were in methadone treatment for OUD. Women's actual experiences with disclosure, shared in in-depth interviews, varied by whether they had disclosed their status intentionally or inadvertently. Approximately one-third (37%) of survey respondents thought a healthcare provider would scold them if they became pregnant; however, all who had been pregnant in the past while on methadone (n = 11) reported disclosing methadone treatment during pregnancy to their provider. Under a quarter of all women (22%) said having a healthy pregnancy while on methadone was likely or very likely. These perceptions were reinforced by negative experiences with providers, or, in many cases, women in the survey reported that they had never discussed the recommendations for a healthy pregnancy while on methadone with a healthcare provider. Discussion: Women experience and anticipate experiencing negative interactions with their healthcare providers if and when they disclose their methadone treatment. These perceptions and experiences impact subsequent treatment seeking and disclosure. The majority of women did not discuss pregnancy with healthcare providers. To improve quality of care, healthcare providers can provide a safe space for women to disclose methadone treatment through nonjudgmental communication that intentionally alleviates stigma. Additionally, healthcare providers should understand medical guidelines and laws/policies around methadone during pregnancy and communicate this understanding to all patients who may wish to become pregnant or who are at risk for unintended pregnancy.
引用
收藏
页数:8
相关论文
共 28 条
  • [1] Nonmedical Prescription Opioid Use and Mental Health and Pain Comorbidities: A Narrative Review
    Amari, Erica
    Rehm, Juergen
    Goldner, Elliot
    Fischer, Benedikt
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2011, 56 (08): : 495 - 502
  • [2] American College of Obstetricians and Gynecologists, 2017, ACOG STAT OP US PREG
  • [3] A Moral or Medical Problem? The Relationship between Legal Penalties and Treatment Practices for Opioid Use Disorders in Pregnant Women
    Angelotta, Cara
    Weiss, Carol J.
    Angelotta, John W.
    Friedman, Richard A.
    [J]. WOMENS HEALTH ISSUES, 2016, 26 (06) : 595 - 601
  • [4] [Anonymous], 2013, The CBHSQ report
  • [5] [Anonymous], 2016, CODING MANUAL QUALIT
  • [6] [Anonymous], 2018, PRINC DRUG ADD TREAT
  • [7] Perceptions of Pregnancy and Contraceptive Use: An In-Depth Study of Women in Los Angeles Methadone Clinics
    Bornstein, Marta
    Gipson, Jessica D.
    Bleck, Roselle
    Sridhar, Aparna
    Berger, Agatha
    [J]. WOMENS HEALTH ISSUES, 2019, 29 (02) : 176 - 181
  • [8] The Changing Face of Heroin Use in the United States A Retrospective Analysis of the Past 50 Years
    Cicero, Theodore J.
    Ellis, Matthew S.
    Surratt, Hilary L.
    Kurtz, Steven P.
    [J]. JAMA PSYCHIATRY, 2014, 71 (07) : 821 - 826
  • [9] "I Just Don't Know": An Exploration of Women's Ambivalence about a New Pregnancy
    Cutler, Abigail
    McNamara, Blair
    Qasba, Neena
    Kennedy, Holly Powell
    Lundsberg, Lisbet
    Gariepy, Aileen
    [J]. WOMENS HEALTH ISSUES, 2018, 28 (01) : 75 - 81
  • [10] Drug Addiction Stigma in the Context of Methadone Maintenance Therapy: An Investigation into Understudied Sources of Stigma
    Earnshaw, Valerie
    Smith, Laramie
    Copenhaver, Michael
    [J]. INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, 2013, 11 (01) : 110 - 122